WPC-1151

GPTKB entity

Properties (64)
Predicate Object
gptkbp:instanceOf chemical compound
gptkbp:chemicalFormula C12H15N3O2
gptkbp:hasAwards serotonin receptors
gptkbp:hasFilm dizziness
nausea
gptkbp:hasWeight 219.27 g/mol
https://www.w3.org/2000/01/rdf-schema#label WPC-1151
gptkbp:isAssociatedWith serotonin syndrome
gptkbp:isAttendedBy gptkb:FDA
oral tablet
other antidepressants
gptkbp:isAvailableIn various dosages
gptkbp:isAvenueFor efficacy
safety profile
gptkbp:isChallengedBy liver enzymes
gptkbp:isCompatibleWith high stability under normal conditions
gptkbp:isConsidered alternative therapy
first-line treatment
off-label use
psychotropic medication
gptkbp:isDiscussedIn medical literature
patient education materials
healthcare_professionals
gptkbp:isDocumentedIn clinical trials registry
gptkbp:isEvaluatedBy quality of life improvement
treatment-resistant depression
gptkbp:isExemplifiedBy urine
gptkbp:isKnownFor improving mood
reducing anxiety
gptkbp:isLinkedTo withdrawal symptoms
weight gain
sexual dysfunction
gptkbp:isMarketedAs brand name A
gptkbp:isPartOf research studies
clinical trials
mental health treatment
treatment protocols
placebo
mental health guidelines
other antidepressants
mental health pharmacotherapy
gptkbp:isPortrayedBy medical journals
gptkbp:isRecognizedFor long-term use
gptkbp:isRelatedTo antidepressants
gptkbp:isStudiedIn depression
animal models
cognitive function
sleep disorders
anxiety disorders
gptkbp:isSubjectTo clinical guidelines
gptkbp:isSuitableFor precursor compounds
gptkbp:isUsedIn pharmaceuticals
clinical psychology
psychopharmacology
gptkbp:isUtilizedFor neurodegenerative diseases
bipolar disorder
chronic pain management
obsessive-compulsive disorder
gptkbp:isUtilizedIn randomized controlled trials
meta-analyses
gptkbp:isVisitedBy gptkb:XYZ_Pharmaceuticals
gptkbp:numberOfFigures 123456-78-9
gptkbp:training liver disease
pregnancy